IBM (IBM.US) presented its Q2 results yesterday after market close. Although most of the results exceeded expectations, the key software segment significantly underperformed, raising doubts about the company's prospects for raising revenue forecasts in H2 2025.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appSource: xStation
In reaction to the results, we saw the largest single-day drop in the company's stock in over a year. The stock lost more than 7% in today's session, and at its peak, it was down by 11%. This means IBM's stock has fully erased all gains built since early June.
Today's IBM drop exceeds the declines seen after "Liberation Day." Source: Bloomberg Finance L.P.
The company's results showed solid revenue growth to $16.98 billion (+7.7%), supported by an improvement in adjusted gross margin to 60.1% (from 57.8% a year earlier). While the company reported solid baseline results, investors often look deeper into individual segments. In IBM's case, one of the most disappointing factors for investors was the software segment, which grew by 9.6% year-on-year to $7.39 billion, $0.1 billion lower than consensus forecasts.
The weakness of this sector casts doubt on the company's prospects for maintaining strong revenue dynamics in the second half of 2025. As this remains the main driver of IBM's results, this information was enough to push the stock down by as much as 7%.
Q2 2025 Results:
-
Revenue: $16.98 billion, up 7.7% year-on-year (estimates: $16.59 billion)
-
Software Revenue: $7.39 billion, up 9.6% year-on-year (estimates: $7.49 billion)
-
Consulting Segment Revenue: $5.31 billion, up 2.6% year-on-year (estimates: $5.21 billion)
-
Infrastructure Revenue: $4.14 billion, up 14% year-on-year (estimates: $3.66 billion)
-
Financing Revenue: $166 million, down 1.8% year-on-year (estimates: $174.4 million)
-
Other Revenue: -$31 million compared to $38 million year-on-year
-
Adjusted Gross Margin: 60.1% compared to 57.8% year-on-year (estimates: 58.3%)
-
Adjusted EPS: $2.80 compared to $2.43 year-on-year (estimates: $2.62)
At the same time, the company did not raise its cash flow expectations, which the consensus had anticipated. This move added some uncertainty to investors' predictions regarding the company's prospects.
The price of a high valuation
While IBM's results remain solid, the market's reaction is partly supported by the company's high valuation. Like the entire US market, the company entered the earnings season with elevated indicators, whose value exceeded not only the averages for the last year but was also at its highest level just before the company's results in over 3 years.
Thus, any blemishes on the company's business prospects strongly affect market sentiment, as we see in today's session. At the same time, even after such a sharp decline, the indicators remain above the averages for the last year, which, relative to historical valuation, leaves room for a possible deepening of the correction if the Q2 2025 results lead to a reduction in expectations regarding the company's performance later in the year.
P/E (blue), P/S (red), and EV/EBITDA (purple) ratios reached their highest values in the session preceding the results in over 3 years. Source: Bloomberg Finance L.P.
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
